Antibiotic stewardship programs in the Spanish emergency services : PROA-URG Study
©The Author 2024. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/)..
OBJECTIVE: Antimicrobial stewardship programs (ASP) have become a key tool in the adaptation of these drugs to the health system. The information available on the application and indicators used in these programs in emergency departments is scarce. The objective of this study is to know the extent of ASP implementation in the emergency departments, as well as the use of antimicrobials in these units.
METHODS: Multicenter retrospective study. An invitation was sent to all participants of the REDFASTER-SEFH emergency pharmacist working group. A questionnaire was used consisting of 21 items, answered by a team made up of a pharmacist, emergency room specialist, infectious disease specialist and microbiologist.
RESULTS: Eighteen hospitals completed the survey. Fourteen (77.8%) had an ASP manager. The DDD value per 1000 admissions ranged between 36.5 and 400.5 (median: 100.4 [IQR:57.2-157.3]). Both carbapenem and macrolide group presented wide variability in use. Six (33.3%) hospitals had an annual report on the specific resistance profile for urine and blood cultures. The percentage of multi-drug resistant strains in urine cultures was 12.5% and in blood cultures 12.2%. The percentage of adequacy in the bacteremia treatment was 81.0% (IQR:74.6-85.0%), while in urinary tract infections was 78.0% (IQR:71.5-88.0).
CONCLUSIONS: Despite the existence of ASP members in emergency services, as well as the training activity and local guidelines is common. knowledge of the use of antimicrobials and resistances is limited. Future activities must be aimed at improving information about the ASP results in these units.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 37(2024), 2 vom: 13. März, Seite 163-169 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Programas de optimización del uso de antimicrobianos en los servicios de urgencias españoles: Estudio PROA-URG |
|---|
| Beteiligte Personen: |
Ruiz Ramos, J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 08.03.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.37201/req/138.2023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368621820 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368621820 | ||
| 003 | DE-627 | ||
| 005 | 20240320234254.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240219s2024 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.37201/req/138.2023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM368621820 | ||
| 035 | |a (NLM)38372121 | ||
| 035 | |a (PII)ruiz19feb2024 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Ruiz Ramos, J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antibiotic stewardship programs in the Spanish emergency services |b PROA-URG Study |
| 246 | 3 | 3 | |a Programas de optimización del uso de antimicrobianos en los servicios de urgencias españoles: Estudio PROA-URG |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.03.2024 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a ©The Author 2024. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/). | ||
| 520 | |a OBJECTIVE: Antimicrobial stewardship programs (ASP) have become a key tool in the adaptation of these drugs to the health system. The information available on the application and indicators used in these programs in emergency departments is scarce. The objective of this study is to know the extent of ASP implementation in the emergency departments, as well as the use of antimicrobials in these units | ||
| 520 | |a METHODS: Multicenter retrospective study. An invitation was sent to all participants of the REDFASTER-SEFH emergency pharmacist working group. A questionnaire was used consisting of 21 items, answered by a team made up of a pharmacist, emergency room specialist, infectious disease specialist and microbiologist | ||
| 520 | |a RESULTS: Eighteen hospitals completed the survey. Fourteen (77.8%) had an ASP manager. The DDD value per 1000 admissions ranged between 36.5 and 400.5 (median: 100.4 [IQR:57.2-157.3]). Both carbapenem and macrolide group presented wide variability in use. Six (33.3%) hospitals had an annual report on the specific resistance profile for urine and blood cultures. The percentage of multi-drug resistant strains in urine cultures was 12.5% and in blood cultures 12.2%. The percentage of adequacy in the bacteremia treatment was 81.0% (IQR:74.6-85.0%), while in urinary tract infections was 78.0% (IQR:71.5-88.0) | ||
| 520 | |a CONCLUSIONS: Despite the existence of ASP members in emergency services, as well as the training activity and local guidelines is common. knowledge of the use of antimicrobials and resistances is limited. Future activities must be aimed at improving information about the ASP results in these units | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anti-Infective Agents | |
| 650 | 4 | |a Antibiotic resistance | |
| 650 | 4 | |a Antimicrobial stewardship | |
| 650 | 4 | |a Emergency care | |
| 650 | 7 | |a Anti-Infective Agents |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Suárez-Lledó Grande, A |e verfasserin |4 aut | |
| 700 | 1 | |a Santolaya Perrín, M R |e verfasserin |4 aut | |
| 700 | 1 | |a Caballero Requejo, C |e verfasserin |4 aut | |
| 700 | 1 | |a Hijazi Vega, M |e verfasserin |4 aut | |
| 700 | 1 | |a López Vinardell, M |e verfasserin |4 aut | |
| 700 | 1 | |a García Martín, A |e verfasserin |4 aut | |
| 700 | 1 | |a Campos Baeta, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Marcos González, A J |e verfasserin |4 aut | |
| 700 | 1 | |a Alonso Díez, M |e verfasserin |4 aut | |
| 700 | 1 | |a Conde Giner, S |e verfasserin |4 aut | |
| 700 | 1 | |a Herrera Carranza, S |e verfasserin |4 aut | |
| 700 | 1 | |a Such Diáz, A |e verfasserin |4 aut | |
| 700 | 1 | |a Prats Riera, M |e verfasserin |4 aut | |
| 700 | 1 | |a Menendez Liendo, L |e verfasserin |4 aut | |
| 700 | 1 | |a Toro Blanch, C |e verfasserin |4 aut | |
| 700 | 1 | |a Revuelta Amallo, A |e verfasserin |4 aut | |
| 700 | 1 | |a Calzón Blanco, C |e verfasserin |4 aut | |
| 700 | 0 | |a PROA-Urgencias group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia |d 1997 |g 37(2024), 2 vom: 13. März, Seite 163-169 |w (DE-627)NLM090649028 |x 1988-9518 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2024 |g number:2 |g day:13 |g month:03 |g pages:163-169 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.37201/req/138.2023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2024 |e 2 |b 13 |c 03 |h 163-169 | ||